SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (13252)9/30/2004 4:25:33 PM
From: IRWIN JAMES FRANKEL  Read Replies (1) | Respond to of 52153
 
>> less than a 1% absolute risk increase? <g>

Do we know that the increase in risk is CAUSED by taking Viox and not by the absence of taking aspirin?

ij



To: Biomaven who wrote (13252)9/30/2004 4:34:30 PM
From: bio_kruncher  Read Replies (1) | Respond to of 52153
 
Yes it is important to look at the absolute numbers.
Some back of the napkin guesses and calculations.

If about half of Vioxx use was chronic(a wild guess) - $ 1B annually at $1000/yr cost makes 1M users.
IF results of the study are reflective of true risk that would means vioxx associated with 7500 cardiac events over 3 years.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News